RXRX
Recursion Pharmaceuticals, Inc.
$4.16+0.42 (11.23%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
4 of 101 tradesExecutives investing their own money
🤖AI Insight
Latest Insider Transactions
Showing 10 of 101 transactions (past 365 days)
| 2026-10-07 | 2026-10-06 | Borgeson Blake | Director | Sale | 50,000 | $4.84 | $242,000 |
| 2026-10-07 | 2026-10-06 | Hershberg Robert | Director | Exercise Conversion | 25,000 | $2.22 | $55,500 |
| 2026-10-07 | 2026-10-06 | Hershberg Robert | Director | Sale | 25,000 | $5.00 | $125,000 |
| 2026-10-07 | 2026-10-06 | Hershberg Robert | Director | Exercise Conversion | 25,000 | $2.22 | $55,500 |
| 2026-10-02 | 2026-10-01 | Dar Zavain | Director | Award | 4,607 | $0.00 | $0 |
| 2026-10-02 | 2026-10-01 | Li Dean Y | Director | Award | 3,378 | $0.00 | $0 |
| 2026-09-10 | 2026-09-08 | Khan Najat | CEO | Sale | 22,408 | $3.52 | $78,831 |
| 2026-09-02 | 2026-09-01 | Borgeson Blake | Director | Sale | 30,000 | $3.34 | $100,200 |
| 2026-08-18 | 2026-08-17 | Hallett David | CSO | Tax Payment | 26,657 | $3.16 | $84,236 |
| 2026-08-18 | 2026-08-17 | Taylor Ben R | CFO | Tax Payment | 25,018 | $3.16 | $79,057 |
RXRX
Director
Exercise Conversion
$55.5K
Hershberg Robert25,000 shares @ $2.22
Filed 2026-10-07Trade 2026-10-06
RXRX
Director
Exercise Conversion
$55.5K
Hershberg Robert25,000 shares @ $2.22
Filed 2026-10-07Trade 2026-10-06
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.